Skip to main content
Scott R. Johnstone

Scott R. Johnstone

Instructor of Research, Cardiovascular Medicine

Primary Location
409 Lane Road
Building MR4, Rm 6071
Charlottesville, Va 22908
Primary Phone Number
Fax Number
801.394.

Bio & Overview

Core research Cardiovascular diseases account for 1:4 deaths. Despite significant improvements in the way in which we successfully treat patients, this still accounts for a significant mortality rate. My research focuses on understanding the molecular mechanisms that regulate normal vascular physiology and the pathophysiology of disease. Defining pathways involved in cardiovascular disease allows us to more effectively target these for therapeutic intervention. Inflammation in vascular disease The primary cause of cardiovascular disease is atherosclerosis, where a buildup of cellular material in the blood vessel walls blocks blood flow. Atherosclerosis is a chronic inflammatory disease, where a prolonged immune reaction results in a change in the composition of the blood vessel. This can lead to complications including thrombosis and stroke. Our research is focused on defining how inflammation is regulated by the cells of the blood vessels wall, and using this information to design the best avenues for future therapeutic intervention. Proliferation in vascular disease Blockages that reduce blood flow to tissues such as the heart and lower limbs are the greatest contributors to CVD, and can result in heart attacks or a requirement for amputations. Treating blocked arteries in patients involves either grafting of blood vessels to bypass the blockage (coronary artery bypass) or implanting support structures called “stents” in the vessel, to open up the blood flow. A side effect of each of these treatments, is that the cells in the blood vessels start to divide (proliferate). This increases the number of cells, and blocks the artery once again. Clinically, this can lead to stent-failure in around 25% of patients and is a significant risk factor. Our research aims to identify new pathways that specifically regulate this process, to help us understand the disease better and to aid the development of targeted therapeutics. Connexin (Cx) proteins and gap junctions Cells communicate in a vast array of ways. The primary source of direct cell-to-cell communication occurs through the gap junction channels comprised of connexin proteins. In particular Cx43, is widely associated with proliferative diseases and shows great promise as a therapeutic target. In addition to their well-established role in coordinating tissue functions, research by our group and others has shown that these are highly diverse proteins, which also regulate cellular processes through direct protein-protein interactions. Our lab focuses on identifying novel pathways involved in the formation of these interactions and ways in which we can manipulate these to target diseased cells. We aim to define the unique molecular pathways controlled by these proteins, and are currently developing a range of inhibitors which show promise in reducing cell proliferation. Our hope is that these inhibitors will be valuable for future development and translation to therapeutics. Pannexin (Panx) channels Identified in 2000, this new class of purine (e.g. ATP) release channels appear to have multiple functions such as regulating cell death (apoptosis), inflammation and blood vessel physiology. Our research pinpoints that pannexin channels allow for a diverse array of signaling events within the vasculature, controlling aspects from blood vessel tone to inflammation. However, signaling regulation via these channels is still poorly understood. Our lab aims to define new molecular signaling pathways regulated by this class of membrane proteins. Our goal is to understand how these proteins are regulated from transcription to translation, and to identify channel functions that control to vascular physiology and pathophysiology.

Academic Information

Department
Cardiovascular Medicine
Academic Title
Instructor of Research

Primary Education

  • PhD, Cell and Molecular Biology, Glasgow Caledonian University, 2008

Other Appointments

  • Instructor of Research, Medicine- Cardiovascular Medicine

Research Interests

Translating molecular mechanisms into therapeutic targets

Research Disciplines

  • Molecular Physiology and Biological Physics

Selected Publications

DeLalio LJ, Billaud M, Ruddiman CA, Johnstone SR, Butcher JT, Wolpe AG, Jin X, Keller TCS, Keller AS, Rivière T, Good ME, Best AK, Lohman AW, Swayne LA, Penuela S, Thompson RJ, Lampe PD, Yeager M, Isakson BE, Constitutive SRC-mediated phosphorylation of pannexin 1 at tyrosine 198 occurs at the plasma membrane., 2019; The Journal of biological chemistry. 294(17) 6940-6956. PMID: 30814251 | PMCID: PMC6497939

Faniku C, O'Shaughnessy E, Lorraine C, Johnstone SR, Graham A, Greenhough S, Martin PEM, The Connexin Mimetic Peptide Gap27 and Cx43-Knockdown Reveal Differential Roles for Connexin43 in Wound Closure Events in Skin Model Systems., 2018; International journal of molecular sciences. 19(2) . PMID: 29463027 | PMCID: PMC5855826

Aasen T, Johnstone S, Vidal-Brime L, Lynn KS, Koval M, Connexins: Synthesis, Post-Translational Modifications, and Trafficking in Health and Disease., 2018; International journal of molecular sciences. 19(5) . PMID: 29701678 | PMCID: PMC5983588

DeLalio LJ, Keller AS, Chen J, Boyce AKJ, Artamonov MV, Askew-Page HR, Keller TCS, Johnstone SR, Weaver RB, Good ME, Murphy SA, Best AK, Mintz EL, Penuela S, Greenwood IA, Machado RF, Somlyo AV, Swayne LA, Minshall RD, Isakson BE, Interaction Between Pannexin 1 and Caveolin-1 in Smooth Muscle Can Regulate Blood Pressure., 2018; Arteriosclerosis, thrombosis, and vascular biology. 38(9) 2065-2078. PMID: 30026274 | PMCID: PMC6202122

Lohman AW, Straub AC, Johnstone SR, Identification of Connexin43 Phosphorylation and S-Nitrosylation in Cultured Primary Vascular Cells., 2016; Methods in molecular biology (Clifton, N.J.). 1437() 97-111. PMID: 27207289

Good ME, Begandt D, DeLalio LJ, Johnstone SR, Isakson BE, Small Interfering RNA-Mediated Connexin Gene Knockdown in Vascular Endothelial and Smooth Muscle Cells., 2016; Methods in molecular biology (Clifton, N.J.). 1437() 71-82. PMID: 27207287

Crespo Yanguas S, Willebrords J, Johnstone SR, Maes M, Decrock E, De Bock M, Leybaert L, Cogliati B, Vinken M, Pannexin1 as mediator of inflammation and cell death., 2016; Biochimica et biophysica acta. Molecular cell research. 1864(1) 51-61. PMID: 27741412 | PMCID: PMC5693326

Sun P, Dong L, MacDonald AI, Akbari S, Edward M, Hodgins MB, Johnstone SR, Graham SV, HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells., 2015; Viruses. 7(10) 5243-56. PMID: 26445057 | PMCID: PMC4632379

Chen CH, Mayo JN, Gourdie RG, Johnstone SR, Isakson BE, Bearden SE, The connexin 43/ZO-1 complex regulates cerebral endothelial F-actin architecture and migration., 2015; American journal of physiology. Cell physiology. 309(9) C600-7. PMID: 26289751 | PMCID: PMC4628939

Lohman AW, Leskov IL, Butcher JT, Johnstone SR, Stokes TA, Begandt D, DeLalio LJ, Best AK, Penuela S, Leitinger N, Ravichandran KS, Stokes KY, Isakson BE, Pannexin 1 channels regulate leukocyte emigration through the venous endothelium during acute inflammation., 2015; Nature communications. 6() 7965. PMID: 26242575 | PMCID: PMC4824045

Johnstone SJ, Wright CS, Martin PE, Overview of the 8th UK Gap Junction meeting - 5th December 2014., 2015; Biochemical Society transactions. 43(3) 447-9. PMID: 26009189

Campbell AS, Johnstone SR, Baillie GS, Smith G, β-Adrenergic modulation of myocardial conduction velocity: Connexins vs. sodium current., 2014; Journal of molecular and cellular cardiology. 77() 147-54. PMID: 25453599

Billaud M, Lohman AW, Johnstone SR, Biwer LA, Mutchler S, Isakson BE, Regulation of cellular communication by signaling microdomains in the blood vessel wall., 2014; Pharmacological reviews. 66(2) 513-69. PMID: 24671377 | PMCID: PMC3973613

Johnstone SR, Going against the flow: the connexin connection in hypertension., 2014; Hypertension (Dallas, Tex. : 1979). 65(3) 502-4. PMID: 25547340

Billaud M, Lohman AW, Straub AC, Parpaite T, Johnstone SR, Isakson BE, Characterization of the thoracodorsal artery: morphology and reactivity., 2012; Microcirculation (New York, N.Y. : 1994). 19(4) 360-72. PMID: 22335567 | PMCID: PMC3335923

Straub AC, Lohman AW, Billaud M, Johnstone SR, Dwyer ST, Lee MY, Bortz PS, Best AK, Columbus L, Gaston B, Isakson BE, Endothelial cell expression of haemoglobin α regulates nitric oxide signalling., 2012; Nature. 491(7424) 473-7. PMID: 23123858 | PMCID: PMC3531883

Johnstone SR, Kroncke BM, Straub AC, Best AK, Dunn CA, Mitchell LA, Peskova Y, Nakamoto RK, Koval M, Lo CW, Lampe PD, Columbus L, Isakson BE, MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation., 2012; Circulation research. 111(2) 201-11. PMID: 22652908 | PMCID: PMC3405546

Lohman AW, Billaud M, Straub AC, Johnstone SR, Best AK, Lee M, Barr K, Penuela S, Laird DW, Isakson BE, Expression of pannexin isoforms in the systemic murine arterial network., 2012; Journal of vascular research. 49(5) 405-16. PMID: 22739252 | PMCID: PMC3482510

Johnstone SR, Billaud M, Lohman AW, Taddeo EP, Isakson BE, Posttranslational modifications in connexins and pannexins., 2012; The Journal of membrane biology. 245(5) 319-32. PMID: 22739962 | PMCID: PMC3954810

Billaud M, Lohman AW, Straub AC, Looft-Wilson R, Johnstone SR, Araj CA, Best AK, Chekeni FB, Ravichandran KS, Penuela S, Laird DW, Isakson BE, Pannexin1 regulates α1-adrenergic receptor- mediated vasoconstriction., 2011; Circulation research. 109(1) 80-5. PMID: 21546608 | PMCID: PMC3135971

Koval M, Billaud M, Straub AC, Johnstone SR, Zarbock A, Duling BR, Isakson BE, Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43., 2011; The American journal of pathology. 178(6) 2536-46. PMID: 21641379 | PMCID: PMC3124229

Looft-Wilson RC, Billaud M, Johnstone SR, Straub AC, Isakson BE, Interaction between nitric oxide signaling and gap junctions: Effects on vascular function., 2011; Biochimica et biophysica acta. 1818(8) 1895-902. PMID: 21835160 | PMCID: PMC3229654

Johnstone SR, Best AK, Wright CS, Isakson BE, Errington RJ, Martin PE, Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function., 2010; Journal of cellular biochemistry. 110(3) 772-82. PMID: 20512937 | PMCID: PMC3030924

Kadl A, Meher AK, Sharma PR, Lee MY, Doran AC, Johnstone SR, Elliott MR, Gruber F, Han J, Chen W, Kensler T, Ravichandran KS, Isakson BE, Wamhoff BR, Leitinger N, Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2., 2010; Circulation research. 107(6) 737-46. PMID: 20651288 | PMCID: PMC2941538

Straub AC, Billaud M, Johnstone SR, Best AK, Yemen S, Dwyer ST, Looft-Wilson R, Lysiak JJ, Gaston B, Palmer L, Isakson BE, Compartmentalized connexin 43 s-nitrosylation/denitrosylation regulates heterocellular communication in the vessel wall., 2010; Arteriosclerosis, thrombosis, and vascular biology. 31(2) 399-407. PMID: 21071693 | PMCID: PMC3056333

Straub AC, Johnstone SR, Heberlein KR, Rizzo MJ, Best AK, Boitano S, Isakson BE, Site-specific connexin phosphorylation is associated with reduced heterocellular communication between smooth muscle and endothelium., 2009; Journal of vascular research. 47(4) 277-86. PMID: 20016202 | PMCID: PMC2895757

Johnstone S, Isakson B, Locke D, Biological and biophysical properties of vascular connexin channels., 2009; International review of cell and molecular biology. 278() 69-118. PMID: 19815177 | PMCID: PMC2878191

Kahn NN, Sinha AK, Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane., 1988; Biochimica et biophysica acta. 972(1) 45-53. PMID: 2902882